Patent ID: 8383593

Claim:
A peptide selected from the group consisting of A20FMDV2 (SEQ ID NO: 8), P — 18INK (SEQ ID NO: 34), P_FMDV2-INK (SEQ ID NO: 35), P_INK-FMDV2 (SEQ ID NO: 36), P_INK-FMDV2-X (SEQ ID NO: 37), P_INK-FMDV2-XX (SEQ ID NO: 38), B-A20FMDV2-Ran (SEQ ID NO: 41), and DBD2 (SEQ ID NO: 16), said A20FMDV2 (SEQ ID NO: 8) and DB2 (SEQ ID NO: 16) being optionally biotinylated, and said peptide optionally comprising a therapeutically active moiety.